5 Results for "

Colo205 tumors

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Colo205 tumors" in MCE Product Catalog:

Cat. No.: HY-143904
CAS No.: 2953426-43-0
Purity:  98.01%
Target:  

PROTACs Mps1

Research Areas:  

Cancer

PROTAC TTK degrader-1 is a PROTAC degrader targeting Threonine Tyrosine Kinase (TTK), with a DC50 of 5.8 nM in HCT-116 cells and 1.7 nM in COLO-205 cells. PROTAC TTK degrader-1 induces the formation of a ternary complex with TTK and the CRBN E3 ubiquitin ligase, triggering proteasome-mediated degradation. PROTAC TTK degrader-1 exhibits activity against colon cancer cells and shows anti-tumor activity in a colon cancer xenograft mouse model. It can be used in colon cancer-related research .
loading...
    loading...
Cat. No.: HY-P991663

Target:  

Tie

Research Areas:  

Cancer

AMG-780 is a fully human IgG2 antibody that targets angiopoietin 1 (Ang1) (IC50 = 4.5 nM) and angiopoietin 2 (Ang2) (IC50 = 0.06 nM). AMG-780 inhibits tumor growth in the Colo205 xenograft mouse model by inhibiting both Ang1 and Ang2. AMG-780 is indicated for the research of cancers such as colon cancer .
loading...
    loading...
Cat. No.: HY-117707
CAS No.: 1581764-31-9
Target:  

Raf

Research Areas:  

Cancer

EBI-907 is an orally active and highly potent B-Raf V600E inhibitor. EBI-907 demonstrates excellent A375 and Colo-205 cellular antiproliferative activity with IC50 values of 13 nM and 14 nM, respectively. EBI-907 can also cause tumor regression in a B-Raf V600E-dependent Colo-205 tumor xenograft model of mice. EBI-907 is promising for research of melanoma and B-Raf V600E associated cancers .
loading...
    loading...
Cat. No.: HY-B1714A
CAS No.: 2070018-27-6
Target:  

Drug Derivative

Research Areas:  

Cancer

NSC 601980 is an anti-tumor compound. In yeast screening experiments, NSC 601980 inhibits cell proliferation in COLO205 and HT29 cell lines with LogGI50 of -6.6 and -6.9, respectively.
loading...
    loading...
Cat. No.: HY-153704
CAS No.: 2035069-96-4
Target:  

CDK

Research Areas:  

Cancer

CDK4/6-IN-17 (compound 12) is an orally active CDK4/6 inhibitor with IC50 ranging of 10-100 nM in BE(2) cells. CDK4/6-IN-17 inhibits tumor growth in COLO205 xenograft model .
loading...
    loading...